Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Via Benzinga
Exposures Product Safety
Tickers LLY NVO
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Vertex Wins An Early Approval; Why It Might Not Move Vertex's Beleaguered Stock
Via Investor's Business Daily
Exposures Product Safety
Tickers VRTX
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?
Via Investor's Business Daily
Exposures Product Safety
Tickers ASX:RMD LLY RMD
Penny Stock Applied Therapeutics' FDA Troubles Trigger Investor Lawsuit, Shareholders Claim Deception Over Govorestat Clinical Data
Via Benzinga
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuits Against DENTSPLY SIRONA Inc. and Encourages Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
XRAY INVESTOR ALERT: Kessler Topaz Meltzer &amp; Check, LLP Announces Securities Fraud Class Action Lawsuits Against DENTSPLY SIRONA Inc. and Encourages Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
What Is a Food Grade Pallet, and Do You Need One?
Via Syndication Cloud
Exposures Product Safety
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Committed to Ensuring Highest Standards in Continued Buntanetap Trials
Via Investor Brand Network
Exposures Product Safety
Tickers ANVS
420 with CNW — DEA Requests Judge to Compel FDA Officials to Testify During Cannabis Reclassification Hearings
Via Investor Brand Network
Topics Cannabis Law Enforcement
Exposures Cannabis Legal Product Safety
420 with CNW — DEA Requests Judge to Compel FDA Officials to Testify During Cannabis Reclassification Hearings
Via CannabisNewsWire
Topics Cannabis Law Enforcement
Exposures Cannabis Legal Product Safety
Tickers CSE:GTII GTBIF
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
Via Benzinga
Exposures Product Safety
Tickers ASX:PXX BSX
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Humacyte Stock Hits Over 1-Month Highs On FDA Nod For Bioengineered Tissue In Treating Vascular Trauma, Retail Interest Soars
Via Stocktwits
Exposures Product Safety
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
Via News Direct
Exposures Product Safety
Tickers CGTX
Quest Diagnostics (NYSE: DGX) And Mainz Biomed (NASDAQ: MYNZ) Team Up To Commercialize ColoAlert Early Cancer Detection Screening In The U.S.
Via News Direct
Exposures Product Safety
Tickers DGX MYNZ TMO
Why Is Bioengineered Human Tissue-Focused Humacyte Stock Surging On Friday?
Via Benzinga
Exposures Product Safety
Tickers HUMA
Tesla Stock Falls Over 5% During Pre-Market After Elon Musk-Led EV Giant Recalls Nearly 700,000 Vehicles
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
Via Benzinga
Exposures Product Safety
Tickers IONS
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025 - Contact Kaplan Fox & Kilsheimer LLP
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
APLT Deadline to Lead in Securities Fraud Lawsuit is February 18, 2025 - Contact Kaplan Fox &amp; Kilsheimer LLP
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Secures $10 Million Debt Facility to Advance Neurodegenerative Disease Treatments
Via Investor Brand Network
Exposures Product Safety
Tickers CLNN
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Via Investor's Business Daily
Exposures Product Safety
Tickers HIMS LLY NVO
Salignostics Secures TGA Approval for Saliva-Based Home Pregnancy Test
Via News Direct
Exposures Product Safety
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
Via Newsfile
Exposures Product Safety
Tickers ASX:COH COCH
EXCLUSIVE: MIRA Pharmaceuticals Files FDA Application To Start Human Trials For Its Lead Pain Treatment
Via Benzinga
Exposures Product Safety
Tickers MIRA
Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges
Via Benzinga
Exposures Product Safety
Tickers ASX:MSB MESO
Jeffrey Allan Parsons Champions the Value of Family and Legacy in Estate Sales
Via Zexprwire
Topics Product Recall
Exposures Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.